Causes and outcomes of internal bleeding in the digestive system

Assessments of epidemiology, aetiology, and outcomes of gastrointestinal bleeding

Registry ID

ISRCTN14750381

Source registry

ISRCTN

Status

Recruiting

Study type

OBSERVATIONAL

Sponsor

Gastroenterology Endowment Fund

Enrollment

9000

Start date

2018-09-15

Completion date

2026-12-31

Last update

2026-08-17

Conditions

• Gastrointestinal bleeding
• Digestive System

Summary

Gastrointestinal bleeding

Detailed description

Patients' details will be anonymised. From their medical records, the following will be analysed: 1. Demography 2. Coexisting conditions 3. Drug therapy 4. Nature of gastrointestinal bleeding (overt, obscure, etc) 5. Length of hospital stay 6. Causes of bleeding 7. Need for transfusion 8. Use of acid inhibitors 9. Need for surgery 10. Other complications of gastrointestinal bleeding 11. Re-bleeding 12. Factors that might help stop bleeding and prevent re-bleeding 12. All-cause mortality

Interventions

• OTHER: Patients' details will be anonymised. From their medical records, the following will be analysed: 1. Demography 2. Coexisting conditions 3. Drug therapy 4. Nature of gastrointestinal bleeding (overt, obscure, etc) 5. Length of hospital stay 6. Causes of bleeding 7. Need for transfusion 8. Use of acid inhibitors 9. Need for surgery 10. Other complications of gastrointestinal bleeding 11. Re-bleeding 12. Factors that might help stop bleeding and prevent re-bleeding 12. All-cause mortality

Inclusion criteria

1. Aged 18 years or older 2. Gastrointestinal bleeding

Exclusion criteria

1. History of previous gastrointestinal surgery 2. Current pregnancy 3. Current use of cytotoxic drugs

Locations

• , , United Kingdom
• , , Scotland

Related clinical trials

• How can we improve care for patients recovering from acute pancreatitis following discharge from hospital?
• Alginate and lifestyle changes in gastro-oesophageal reflux disease
• Effects of thoracic epidural anesthesia in patients with acute pancreatitis and early organ failure
• Supporting patients’ adaption process in liver cirrhosis
• Randomised treatment of Acute Pancreatitis with Infliximab: Double-blind, placebo-controlled, multi-centre trial
• A study of guselkumab versus risankizumab in participants with moderately to severely active Crohn's Disease

View on source registry